| Item type |
学内発行雑誌 / Departmental Bulletin Paper(1) |
| 公開日 |
2020-06-01 |
| タイトル |
|
|
タイトル |
Complete Response Using Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma with Multiple Lymph Node and Bone Metastases: A Case Report |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ |
departmental bulletin paper |
| 著者 |
NOMURA, Norihiro
ITO, Takayoshi
SHINOHARA, Hiroki
SHIMA, Nobukazu
SATOU, Masashi
SAKUMA, Dai
EGUCHI, Junichi
URAGAMI, Naoyuki
DEGUCHI, Yoshio
YOKOYAMA, Noboru
INOUE, Haruhiro
|
| 書誌情報 |
The Showa University journal of medical sciences
巻 31,
号 4,
p. 373-378,
発行日 2019-12
|
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Hepatocellular carcinoma（HCC）is the sixth most commonly diagnosed cancer worldwide. Sorafenib is an oral multikinase inhibitor used in the palliative treatment of advanced HCC. However, there were no reported cases of complete response（CR）from two previous large phaseⅢ clinical trials. Here, we report a case of CR in a patient with advanced HCC with multiple lymph node and bone metastases, treated with sorafenib monotherapy for 8 months. To our knowledge, this is the first evidence showing CR following sorafenib monotherapy for HCC with bone metastasis. |
| DOI |
|
|
|
関連識別子 |
10.15369/sujms.31.373 |
| 出版者 |
|
|
出版者 |
Showa University Society |
| ISSN |
|
|
収録物識別子 |
0915-6380 |
| 出版タイプ |
|
|
出版タイプ |
VoR |
S31_373.pdf (337.4 kB)
